降低LDL-C药物的演变及其心血管益处:过去,现在和未来
Mohammed Faluk1, Abdirahman Wardhere2, Abdilahi Mohamoud3
1Division of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Current problems in cardiology
|May 12, 2024
概括
通过降低低密度脂蛋白胆固醇 (LDL-C) 来降低心血管疾病 (CVD) 的风险. 本综述详细介绍了降低LDL-C的疗法的进展,从旧药物到新兴的口服PCSK9抑制剂.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 医学研究 医学研究
背景情况:
- 心血管疾病 (CVD) 仍然是全球首要的死亡原因.
- 升高的低密度脂蛋白胆固醇 (LDL-C) 是一个重要的心血管疾病风险因素.
- 临床试验证实,减少LDL-C有效降低心血管事件.
研究的目的:
- 审查LDL-C降低药物的历史发展和当前景观.
- 突出从传统疗法向新药药物剂的进展.
- 引入新兴治疗方法,包括口服PCSK9抑制剂.
主要方法:
- 对具有里程碑意义的临床试验和药理学进展的文献综述.
- 讨论针对降低LDL-C的药物类别.
- 从胆汁酸分离剂到PCSK9抑制剂的治疗进化概述.
主要成果:
- 通过降低LDL-C的疗法,可以显著减少心血管事件.
- 治疗疗效通常与LDL-C降低的程度相关.
- 一系列创新的LDL-C降低药物正在通过临床试验取得进展.
结论:
- 降低LDL-C药物的演变对心血管疾病管理产生了重大影响.
- 新型疗法,如PCSK9抑制剂,为实现目标LDL-C水平提供了新的策略.
- 目前正在进行的研究,包括口服PCSK9抑制剂的第三阶段试验,有望在心血管疾病预防方面取得进一步进展.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
652
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
155
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
155
Adrenergic Antagonists: ɑ and β-Receptor Blockers
439
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
439
Cholesterol: Significance and Regulation
539
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
539
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521


